JPRN-UMIN000041326尚未招募未知
Effect of Esaxerenone, a novel mineralocorticoid receptor antagonist on insulin resistance in diabetic patients with hypertension. - Effect of Esaxerenone, a novel mineralocorticoid receptor antagonist on insulin resistance in diabetic patients with hypertension.
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients treated with insulin 2. Patients treated with steroid 3. Patients with renal disfunction(eGFR<60) 4. Patients with hyperkalemia(K>5.0mEq/L) 5. Pregnant or nursing patients
研究者
相似试验
尚未招募
2 期
Effects of Mineralocorticoid Receptor Blockade on Metabolism - A Clinical TrialMetabolic and Endocrine - Metabolic disordersDiet and Nutrition - ObesityObesityACTRN12618001958279Dr Moe Thuzar32
已完成
不适用
The effect of a mineralocorticoid receptor antagonist eplerenone on morning home BP in drug-resistant hypertensiodrug-resistant morning hypertensionJPRN-UMIN000014186Jichi Medical University School of Medicine100
进行中（未招募）
不适用
Effects of eplerenone on forearm blood flowhealthy volunteersEUCTR2013-000189-12-NLniversity Medical Centre Nijmegen
已完成
不适用
Effects of the selective mineralocorticoid receptor antagonist eplerenone on extracellular adenosine formation in humans in vivoblood flowischemia reperfusion injury10011082NL-OMON38928niversitair Medisch Centrum Sint Radboud14
已完成
4 期
Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in ObesityMetabolic SyndromeOverweight and ObesityHypertensionNCT04519164Brigham and Women's Hospital79